Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05474235 · ClinicalTrials.gov registry record

Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Motor Neuron Disorders

A clinical trial of Amyotrophic Lateral Sclerosis, sponsored by Mayo Clinic.

Recruiting
Registry status
3,000
Enrollment target
1
Study location

NCT05474235 is a study of Amyotrophic Lateral Sclerosis that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 3,000 participants, above the 869-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (245% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05474235, a study of Amyotrophic Lateral Sclerosis, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
3,000 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to collect, from patients with sporadic and familial ALS and their family members, clinical data and blood samples for extraction of DNA, RNA, preparation of lymphocytes, plasma and serum to establish a repository for future investigations of genetic contributions to ALS pathogenesis. Blood samples for DNA extraction also would be collected from control subjects with no personal or family history of ALS phenotypes.

Study Locations (1)

Florida

  • Mayo Clinic Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 2007-12
Est. Completion 2038-12

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05474235

The ClinicalTrials.gov registry entry for NCT05474235 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 869-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (245% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT05474235 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05474235 about?

NCT05474235 is a clinical study titled "Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Motor Neuron Disorders". The purpose of this study is to collect, from patients with sporadic and familial ALS and their family members, clinical data and blood samples for extraction of DNA, RNA, preparation of lymphocytes, plasma and serum to establish a repository for future investigations of genetic contributions to ALS...

What is the current status of trial NCT05474235?

This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2007-12. Estimated completion is 2038-12.

What conditions does trial NCT05474235 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis.

Who is sponsoring clinical trial NCT05474235?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05474235 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.